Research
New research from the University University of Maryland’s National Consortium for the Study of Terrorism and Responses to Terrorism (START) found tremendous diversity in hate crime offenders' backgrounds and motivations.
Researchers determined that these criminals are a diverse group, varying... Read More »
Researchers from McGill University are tracking the global race for a COVID-19 vaccine with a new online tool that tracks real-time progress on the development of the more than 50 candidates currently in human trials.
"Our goal with the vaccine tracker is to help the public find and access... Read More »
Leaders of the effort to develop a COVID-19 vaccine said Tuesday more than 60,000 Americans have volunteered to participate in clinical trials at six different pharma companies with the goal to begin distributing a vaccine by January.
Operation Warp Speed, created by the Trump administration... Read More »
The Defense Advanced Research Projects Agency’s (DARPA) SIGMA+ program conducted a test of advanced chemical and biological sensing systems in the Indianapolis area this past August.
DARPA collected more than 250 hours of daily life background atmospheric data in the city that helped train... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) gained a $20 million investment from the U.S. Agency for International Development (USAID) last week to support the development of vaccines targeting emerging infectious diseases.
These funds will be provided over a five year period,... Read More »
Roche and Atea Pharmaceuticals, Inc. are now collaborating on the development, manufacture, and distribution of AT-527, an Atea-created investigational oral antiviral for use on COVID-19.
The drug, which is currently in phase two clinical trials for hospitalized patients with moderate COVID-19,... Read More »
While the pursuit of treatments and vaccines for COVID-19 is ongoing, the U.S. Food and Drug Administration (FDA) announced a major milestone last week with the approval of the first treatment for the deadly disease: Gilead Sciences Inc.’s Veklury, also known as remdesivir.
The approval is... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) has expanded the manufacturing network for its COVID-19 vaccine portfolio.
The nonprofit foundation, which finances independent research projects to develop vaccines against emerging infectious diseases, has signed vaccine manufacturing... Read More »
National Geospatial-Intelligence Agency (NGA) officials said a geospatial technology lab slated for launch at the T-REX innovation center in St. Louis, Missouri, would advance regional NGA, industry, and academia efforts.
“We will deliver trusted GEOINT with the speed, accuracy, and precision... Read More »
Researchers with The Pew Charitable Trusts have found that expanding access to naloxone, and changing public policy to ensure the opioid-overdose reversal drug gets into the hands of those who need it, can reduce opioid-related overdose deaths.
Additionally, researchers said, expanded access to... Read More »
BioIndustrial Manufacturing and Design Ecosystem (BioMADE) has secured an $87 million Department of Defense (DoD) pact for a new Manufacturing Innovation Institute (MII).
The seven-year award to the University of Minnesota-based firm will collaborate with public and private entities to advance... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) has enlisted its clinical studies network's services to assist with a COVID-19 clinical trial.
Officials said Technical Resources International, Inc. (TRI), a BARDA subsidiary, would support the clinical trial in conjunction... Read More »
The National Institute for Biological Standards and Control (NIBSC) in the United Kingdom and Q2 Solutions in the United States became the latest labs to join the Coalition for Epidemic Preparedness Innovations’ (CEPI) centralized laboratory network for COVID-19 vaccines this week.
“We are... Read More »
A cooperative effort between The University of Texas Health Science Center at Houston (UTHealth) and the Texas Department of State Health Services (DSHS) gave life to the Texas Coronavirus Antibody Response Survey (CARES) this week, to chart how many people in Texas have COVID-19... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) awarded contracts this week to ICON Government & Public Health Solutions, Pharm-Olam LLC, PRA Health Sciences, Inc., and Technical Resources International, Inc. for the development of various medical countermeasures.
Granted... Read More »
The National Institutes of Health kicked off a large, phase three clinical trial last week to chart the safety and efficacy of three modulator drugs being considered for use on patients hospitalized with COVID-19.
The three drugs to be used are Janssen Research & Development, LLC’s infliximab... Read More »
A randomized control trial on COVID-19 therapeutics has generated conclusive evidence on the effectiveness of repurposed drugs -- like remdesivir and hydroxychloroquine, among others -- to treat COVID-19.
The results from the Solidarity Therapeutics Trial, coordinated by the World Health... Read More »
A new report by the Rand Corporation finds that Facebook users would be less likely to spread Russian propaganda if they knew it emanated from a Russian source.
Russia uses political memes to polarize Americans, particularly those at the extreme ends of the political spectrum, according to Rand... Read More »
Another COVID-19 vaccine candidate shows promise for antibodies produced, at least in preclinical results released by Sanofi Pasteur and Translate Bio last week for their mRNA-based offering, MRT5500.
The candidate produced neutralizing antibodies against SARS-CoV-2 -- the virus that causes... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Beckman Coulter are joining forces to fund a multi-center clinical trial of Beckman Coulter’s Monocyte Distribution Width (MDW) hematology biomarker, a test meant to rapidly detect MIS-C.
MIS-C, or Multisystem Inflammatory... Read More »
Researchers with the U.S. Army Futures Command are developing alternative ways to measure COVID-19 antibody levels that are faster, easier, and less expensive.
Their work revolves around finding alternatives to measuring virus neutralization, or VN, titers. This process is the gold standard of... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) launched a study to determine whether certain approved therapies or investigational drugs show promise against COVID-19.
The ACTIV-5 Big Effect Trial is being conducted in partnership with the National Institutes of Health’s... Read More »
U.S. Reps. Kevin McCarthy (R-CA) and David Schweikert (R-CA) commended the National Institute of Allergy and Infectious Diseases’ (NIAID) for establishing a research initiative to treat and prevent Valley Fever.
The NIAID recently issued a notice of funding opportunity to establish a... Read More »
A $481 million award from the Biomedical Advanced Research and Development Authority (BARDA) and Department of Defense (DoD) this week will help Cue Health, Inc. expand the production capacity of a cartridge-based point-of-care molecular test for COVID-19.
With the fund injection, Cue aims to... Read More »
The U.S. Departments of Health and Human Services (HHS) and Defense (DoD) announced greater collaboration with AstraZeneca last week, specifically aimed at the late-stage development and manufacturing of its COVID-19 treatment, AZD7442.
AZD7442 is a drug cocktail made up of two monoclonal... Read More »
Congressional leaders on the House Energy and Commerce Committee are seeking a review by the Government Accountability Office (GAO) of cybersecurity incident response capabilities of the Department of Health and Human Services (HHS).
The E&C leaders said the HHS needs to be able to manage... Read More »
Defense Advanced Research Projects Agency (DARPA) personnel are espousing the benefits of the department’s DARPA’s Robotic Autonomy in Complex Environments with Resiliency (RACER) program.
Authorities said RACER seeks to ensure algorithms are not the limiting part of the system and... Read More »
Election interference has sounded many alarms this year, all the way to the White House and the halls of Congress. Now, the Rand Corporation is warning that a coordinated effort on Twitter to influence and provoke chaos during the upcoming presidential election is underway.
“Social media has... Read More »
Under a new partnership, the Biomedical Advanced Research and Development Authority (BARDA) will collaborate with Current Health to develop an algorithm based on a Food and Drug Administration (FDA) approved wearable monitor to predict the need for COVID-19 hospitalization.
By forecasting the... Read More »
Emergent BioSolutions Inc. is one of four companies collaborating to provide hyperimmune globulin products for a new federal clinical trial that will test the safety, tolerability and efficacy of a combination treatment regimen for COVID-19.
The regimen consists of the antiviral remdesivir plus... Read More »
U.S. Sens. Thom Tillis (R-NC) and Marsha Blackburn (R-TN) introduced a bill that would give the president the authority to sanction foreign nations that try to steal American research on COVID-19.
The Defend COVID Research from Hackers Act authorizes sanctions that would specifically target a... Read More »
A new test being developed by molecular diagnostics company Cepheid gained support from federal agencies this week, on the promise that it could become a one-stop-shop for diagnosing COVID-19, influenza, and RSV.
Support is coming from the Biomedical Advanced Research and Development Authority... Read More »
The Department of Homeland Security (DHS) released its Homeland Threat Assessment (HTA) – a report that synthesizes threat information across DHS, including intelligence and operational components.
“This HTA is as close as the American people will get to seeing and understanding the... Read More »
Biological materials management and standards organization ATCC has secured a potential 10-year, Indefinite Delivery/Indefinite Quantity (IDIQ) contract award from the Biomedical Advanced Research and Development Authority (BARDA).
The agreement, which possesses a ceiling value of $250 million,... Read More »
Over the course of three years, the Biomedical Advanced Research and Development Authority (BARDA) will pay approximately $22 million to Vaxxas to fund phase 1 clinical trials in the U.S. and Australia for a high-density microarray patch capable of administering vaccines needle-free.
This comes... Read More »
